The CFX Opus 96 Dx System and the CFX Opus 384 Dx System are the latest additions to Bio-Rad’s portfolio of real-time PCR instruments. The systems offer quantification to improve assay development, ...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) a global leader in life science research and clinical diagnostics products, today announced a collaboration agreement with Oncocyte Corporation (Nasdaq ...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today announced the launch of an RT-PCR kit that allows researchers to simultaneously screen samples for Zika (ZIKV), dengue (DENV1, DENV2, DENV3, DENV4 ...
Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, today announced the launch of its first ultrasensitive multiplexed digital PCR assay, the ddPLEX ...
Over the past four years, many of us have become accustomed to a swab up the nose to test for COVID-19, using at-home rapid antigen tests or the more accurate clinic-provided PCR tests with a longer ...
Waterborne pathogens lead to deteriorating water quality and challenge global health and economy. The latest U.S. Environmental Protection Agency (EPA) Contaminant Candidate List (CCL4) contained 12 ...
Dipylon Medical Expands Access to Clinical Microbiology Equipment for Modern Diagnostic Laboratories
Expanding access to advanced PCR thermocyclers, DNA & RNA purification systems, and hematology analyzers for modern clinical ...
The CFX Opus Deepwell System has been added to the Bio-Rad™ portfolio of CFX Opus Real-Time PCR instruments. With a 96-well block, the CFX Opus Deepwell System was designed to offer quantification to ...
A new diagnostic tool developed by researchers can test for SARS-CoV-2 and Zika virus with the same or better accuracy as high-precision PCR tests in a matter of hours. Over the past four years, many ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results